Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19

Abstract

The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health threat worldwide with millions of people at risk in a growing number of countries. Though there are no clinically approved antiviral drugs and vaccines for COVID-19, attempts are ongoing for clinical trials of several known antiviral drugs, their combination, as well as development of vaccines in patients with confirmed COVID-19. This review focuses on the latest approaches to diagnostics and therapy of COVID-19. We have summarized recent progress on the conventional therapeutics such as antiviral drugs, vaccines, anti-SARS-CoV-2 antibody treatments, and convalescent plasma therapy which are currently under extensive research and clinical trials for the treatment of COVID-19. The developments of nanoparticle-based therapeutic and diagnostic approaches have been also discussed for COVID-19. We have assessed recent literature data on this topic and made a summary of current development and future perspectives.

References 184

1. 1.

   Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007;20(4):660-694.

   Not in our library10.1128/cmr.00023-07

2. 2.

   Girard MP, Tam JS, Assossou OM, Kieny MP. The 2009 a (H1N1) influenza virus pandemic: a review. Vaccine. 2010;28(31):4895-4902.

   Not in our library10.1016/j.vaccine.2010.05.031

3. 3.

   Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386(9997):995-1007.

   Not in our library10.1016/s0140-6736(15)60454-8

4. 4.

   Oleribe OO, Salako BL, Ka MM, Akpalu A, McConnochie M, Foster M, et al. Ebola virus disease epidemic in West Africa: lessons learned and issues arising from West African countries. Clin Med. 2015;15:54-57.

   Not in our library10.7861/clinmedicine.15-1-54

5. 5.

   Agumadu VC, Ramphul K. Zika virus: a review of literature. Cureus. 2018;10(7):e3025.

   Not in our library10.7759/cureus.3025

6. 6.

   World Health, Organization. Novel coronavirus (2019-nCoV): situation report, 1. Geneva: World Health Organization; 2020. https://apps.who.int/iris/handle/10665/330760. Accessed 2020-01-21.

   Not in our library

7. 7.
   The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 · 2020

   No notice
8. 8.
   Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern · 2020

   No notice
9. 9.

   WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health, Organization (WHO); 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virusthat-causes-it.

   Not in our library

10. 10.

    Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91((1):157-160.

    Not in our library10.23750/abm.v91i1.9397

11. 11.

    Coronavirus disease (COVID-19) pandemic. World Health Organization; 2020 [cited 2020 10/31/2020]; Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=Cj0KCQjwlvT8BRDeARIsAACRFiW_AoKe8cr7J7MyGq46ojb4LEDnznIAUBkEXISSPxIfKCLbfmxjYgUaAriBEALw_wcB.

    Not in our library

12. 12.
    Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China · 2020

    No notice
13. 13.

    Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733.

    Not in our library10.1056/nejmoa2001017

14. 14.

    Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24(6):490-502.

    Not in our library10.1016/j.tim.2016.03.003

15. 15.

    Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020;26(6):729-734.

    Not in our library10.1016/j.cmi.2020.03.026

16. 16.

    Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, et al. Diagnosing COVID-19: the disease and tools for detection. ACS Nano. 2020;14(4):3822-3835.

    Not in our library10.1021/acsnano.0c02624

17. 17.

    Khan I, Ahmed Z, Sarwar A, Jamil A, Anwer F. The potential vaccine component for COVID-19: a comprehensive review of global vaccine development efforts. Cureus. 2020;12(6):e8871.

    Not in our library10.7759/cureus.8871

18. 18.

    Goldman-Israelow B. Coronavirus replication cycle (template). BioRender.com; 2020 [cited 2020 11/01/2020]; Available from: https://app.biorender.com/biorender-templates/figures/5e99f5395fd61e0028682c01/t-5e56d97d1b689000850f8f93-coronavirus-replication-cycle.

    Not in our library

19. 19.

    Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, Li SB, Wang HY, Zhang S, Gao HN, Sheng JF, Cai HL, Qiu YQ, Li LJ. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:m606.

    Not in our library10.1136/bmj.m606

20. 20.

    Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513.

    Not in our library10.1016/s0140-6736(20)30211-7

21. 21.

    Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239-1242.

    Not in our library10.1001/jama.2020.2648

22. 22.

    Han C, Duan C, Zhang S, Spiegel B, Shi H, Wang W, et al. Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. Am J Gastroenterol. 2020;115(6):916-923.

    Not in our library10.14309/ajg.0000000000000664

23. 23.

    Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol. 2020;115(5):766-773.

    Not in our library10.14309/ajg.0000000000000620

24. 24.

    Liu W, Zhang Q, Chen J, Xiang R, Song H, Shu S, et al. Detection of COVID-19 in children in early January 2020 in Wuhan, China. N Engl J Med. 2020;382:1370-1371.

    Not in our library10.1056/nejmc2003717

25. 25.

    Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382:1663-1665.

    Not in our library10.1056/nejmc2005073

26. 26.

    Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020;63(5):706-711.

    Not in our library10.1007/s11427-020-1661-4

27. 27.

    Wang Y, Liu Y, Liu L, Wang X, Luo N, Li L. Clinical outcomes in 55 patients with severe acute respiratory syndrome coronavirus 2 who were asymptomatic at hospital admission in Shenzhen, China. J Infect Dis. 2020;221(11):1770-1774.

    Not in our library10.1093/infdis/jiaa119

28. 28.
    Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 · 2020

    Corrected
29. 29.

    Pan X, Chen D, Xia Y, Wu X, Li T, Ou X, et al. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. Lancet Infect Dis. 2020;20(4):410-411.

    Not in our library10.1016/s1473-3099(20)30114-6

30. 30.

    Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki SI, Ishihara T, et al. Natural history of asymptomatic SARS-CoV-2 infection. N Engl J Med. 2020. 10.1056/NEJMc2013020.

    Not in our library10.1056/nejmc2013020

31. 31.

    Wang Y, Kang H, Liu X, Tong Z. Asymptomatic cases with SARS-CoV-2 infection. J Med Virol. 2020. 10.1002/jmv.25990.

    Not in our library10.1002/jmv.25990

32. 32.

    Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41-58.

    Not in our library10.1038/nrd.2018.168

33. 33.

    Bauchner H, Fontanarosa PB. Randomized clinical trials and COVID-19: managing expectations. JAMA. 2020;323(22):2262-2263.

    Not in our library10.1001/jama.2020.8115

34. 34.

    Ahidjo BA, Loe MWC, Ng YL, Mok CK, Chu JJH. Current perspective of antiviral strategies against COVID-19. ACS Infect Dis. 2020;6:1624-1634.

    Not in our library10.1021/acsinfecdis.0c00236

35. 35.

    Malik S, Gupta A, Zhong X, Rasmussen TP, Manautou JE, Bahal R. Emerging therapeutic modalities against COVID-19. Pharmaceuticals (Basel). 2020;13(8):188.

    Not in our library10.3390/ph13080188

36. 36.

    COVID-19 Vaccine tracker. 2020 [cited 2020 08/08/2020]; Available from:https://biorender.com/covid-vaccine-tracker.

    Not in our library

37. 37.
    Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China · 2020

    No notice
38. 38.

    Correia IR. Stability of IgG isotypes in serum. mAbs. 2010;2(3):221-232.

    Not in our library10.4161/mabs.2.3.11788

39. 39.
    Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model · 2020

    No notice
40. 40.

    Liu C, Zhou Q, Li Y, Garner LV, Watkins SP, Carter LJ, et al. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci. 2020;6(3):315-331.

    Not in our library10.1021/acscentsci.0c00272

Cited by papers we hold 6

• Severity-specific immune landscape of COVID-19 revealed by single-cell sequencing · 2025
  Not checked
• Comunicação em saúde sobre COVID-19 e Diabetes Mellitus em mídias sociais: verdadeiro e falso · 2022
  Not checked
• When to test for COVID-19 using real-time reverse transcriptase polymerase chain reaction: a systematic review · 2022
  Not checked
• SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines · 2022
  No notice
• Effect of internet-delivered cognitive behavioral therapy on insomnia in convalescent patients with COVID-19: Protocol for a systematic review and meta-analysis. · 2022
  Not checked
• A new perspective of hypothalamic disease: Shapiro's syndrome · 2022
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.